RYCCX
Price
$513.32
Change
+$8.20 (+1.62%)
Updated
Dec 2 closing price
Net Assets
1.47B
UOPSX
Price
$100.87
Change
+$1.63 (+1.64%)
Updated
Dec 2 closing price
Net Assets
1.69B
Interact to see
Advertisement

RYCCX vs UOPSX

Header iconRYCCX vs UOPSX Comparison
Open Charts RYCCX vs UOPSXBanner chart's image
Rydex NASDAQ-100® 2x Strategy C
Price$513.32
Change+$8.20 (+1.62%)
VolumeN/A
Net Assets1.47B
ProFunds UltraNASDAQ-100 Svc
Price$100.87
Change+$1.63 (+1.64%)
VolumeN/A
Net Assets1.69B
RYCCX vs UOPSX Comparison Chart in %
View a ticker or compare two or three
VS
RYCCX vs. UOPSX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYCCX is a Buy and UOPSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UOPSX has more cash in the bank: 1.69B vs. RYCCX (1.47B). RYCCX (0.00) and UOPSX (0.00) have matching dividends . RYCCX was incepted earlier than UOPSX: RYCCX (25 years) vs UOPSX (28 years). RYCCX (2.62) and UOPSX (2.53) have similar cost to investors . RYCCX is a more actively managed with annual turnover of: 383.00 vs. UOPSX (22.00). RYCCX has a lower initial minimum investment than UOPSX: RYCCX (2500) vs UOPSX (15000). UOPSX annual gain was more profitable for investors over the last year : 24.05 vs. RYCCX (18.44). RYCCX return over 5 years is better than : 91.41 vs. UOPSX (60.43).
RYCCXUOPSXRYCCX / UOPSX
Total Expense Ratio2.502.5399%
Annual Report Gross Expense Ratio2.622.53104%
Fund Existence25 years28 years-
Gain YTD30.46526.900113%
Front LoadN/AN/A-
Min. Initial Investment25001500017%
Min. Initial Investment IRAN/AN/A-
Net Assets1.47B1.69B87%
Annual Yield % from dividends0.000.00-
Returns for 1 year18.4424.0577%
Returns for 3 years201.44190.81106%
Returns for 5 years91.4160.43151%
Returns for 10 years594.88572.04104%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENGGF16.20N/A
N/A
Enagas S.A.
ALPMF12.23N/A
N/A
Astellas Pharma, Inc.
AVNBF23.40N/A
N/A
AVON TECHNOLOGIES PLC
HOFBF0.17N/A
N/A
Hofseth Biocare ASA
FNTTF0.26N/A
N/A
XR IMMERSIVE TECH INC.